tykhr
sign in
free sign up
Allogene Therapeutics Inc
Biotechnology
Healthcare
ALLO
215 M shares
NASDAQ US
traded
29 Jul 2025
listed
no
open
1.47
52 week high
3.50
high
1.48
52 week low
0.00
low
1.40
growth
-45.53 %
previous Close
1.47
P/E ratio
market cap
262 M
div yield
0
usd
Mar 2025
qoq
revenue
0.00 %
net incoming
-59.73 M
0.34 %
eps
0.00 %
0.00 %
eps surprise
31.71 %
net profit margin
-5973300000.00 %
-2724.50 %
operating incoming
-65.19 M
-7.77 %
net change in cash
-32.76 M
-236.63 %
cash on hand
42.46 M
-43.56 %
cost of revenue
0.00 %
top